גליאדל

Država: Izrael

Jezik: hebrejski

Izvor: Ministry of Health

Aktivni sastojci:

CARMUSTINE

Dostupno od:

MEGAPHARM LTD

ATC koda:

L01AD01

Farmaceutski oblik:

פרוסה

Sastav:

CARMUSTINE 7.7 MG

Administracija rute:

שתל

Tip recepta:

מרשם נדרש

Proizveden od:

EISAI INC, USA

Terapijska grupa:

CARMUSTINE

Područje terapije:

CARMUSTINE

Terapijske indikacije:

For use as an adjunct to surgery to prolong survival in patients with recurrent glioblastoma multiforme for whom surgical resection is indicated. Gliadel implant is indicated in newly-diagnosed high-grade malignant glioma patients as an adjunct to surgery and radiation. Gliadel implant is indicated for use as an adjunct to surgery in patients with Recurrent histogically proved glioblastoma multiforme for whom surgical resection is indicated.

Datum autorizacije:

2023-05-31